BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 28618268)

  • 1. Antigen Availability Shapes T Cell Differentiation and Function during Tuberculosis.
    Moguche AO; Musvosvi M; Penn-Nicholson A; Plumlee CR; Mearns H; Geldenhuys H; Smit E; Abrahams D; Rozot V; Dintwe O; Hoff ST; Kromann I; Ruhwald M; Bang P; Larson RP; Shafiani S; Ma S; Sherman DR; Sette A; Lindestam Arlehamn CS; McKinney DM; Maecker H; Hanekom WA; Hatherill M; Andersen P; Scriba TJ; Urdahl KB
    Cell Host Microbe; 2017 Jun; 21(6):695-706.e5. PubMed ID: 28618268
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Clemmensen HS; Dube JY; McIntosh F; Rosenkrands I; Jungersen G; Aagaard C; Andersen P; Behr MA; Mortensen R
    mBio; 2021 Apr; 12(2):. PubMed ID: 33879592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rescuing ESAT-6 Specific CD4 T Cells From Terminal Differentiation Is Critical for Long-Term Control of Murine Mtb Infection.
    Clemmensen HS; Knudsen NPH; Billeskov R; Rosenkrands I; Jungersen G; Aagaard C; Andersen P; Mortensen R
    Front Immunol; 2020; 11():585359. PubMed ID: 33240275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Ag85B protein of Mycobacterium tuberculosis may turn a protective immune response induced by Ag85B-DNA vaccine into a potent but non-protective Th1 immune response in mice.
    Palma C; Iona E; Giannoni F; Pardini M; Brunori L; Orefici G; Fattorini L; Cassone A
    Cell Microbiol; 2007 Jun; 9(6):1455-65. PubMed ID: 17250590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T Cells Primed by Live Mycobacteria Versus a Tuberculosis Subunit Vaccine Exhibit Distinct Functional Properties.
    Lindenstrøm T; Moguche A; Damborg M; Agger EM; Urdahl K; Andersen P
    EBioMedicine; 2018 Jan; 27():27-39. PubMed ID: 29249639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B Cells and Programmed Death-Ligand 2 Signaling Are Required for Maximal Interferon-γ Recall Response by Splenic CD4⁺ Memory T Cells of Mice Vaccinated with Mycobacterium tuberculosis Ag85B.
    Riccomi A; Palma C
    PLoS One; 2015; 10(9):e0137783. PubMed ID: 26379242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine expressing a fusion protein of Ag85B-Esat6-HspX in mice.
    Yuan W; Dong N; Zhang L; Liu J; Lin S; Xiang Z; Qiao H; Tong W; Qin C
    Vaccine; 2012 Mar; 30(14):2490-7. PubMed ID: 21704108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells.
    Badell E; Nicolle F; Clark S; Majlessi L; Boudou F; Martino A; Castello-Branco L; Leclerc C; Lewis DJ; Marsh PD; Gicquel B; Winter N
    Vaccine; 2009 Jan; 27(1):28-37. PubMed ID: 18977269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-tuberculosis immunity induced in mice by vaccination with Mycobacterium smegmatis over-expressing Antigen 85B is due to the increased influx of IFNgamma-positive CD4 T cells into the lungs.
    Lindsey DR; Dhandayuthapani S; Jagannath C
    Tuberculosis (Edinb); 2009 Dec; 89 Suppl 1(Suppl 1):S46-8. PubMed ID: 20006304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcutaneous administration of modified vaccinia virus Ankara expressing an Ag85B-ESAT6 fusion protein, but not an adenovirus-based vaccine, protects mice against intravenous challenge with Mycobacterium tuberculosis.
    You Q; Jiang C; Wu Y; Yu X; Chen Y; Zhang X; Wei W; Wang Y; Tang Z; Jiang D; Wu Y; Wang C; Meng X; Zhao X; Kong W
    Scand J Immunol; 2012 Jan; 75(1):77-84. PubMed ID: 21916923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA-Launched Alphavirus Replicons Encoding a Fusion of Mycobacterial Antigens Acr and Ag85B Are Immunogenic and Protective in a Murine Model of TB Infection.
    Dalmia N; Klimstra WB; Mason C; Ramsay AJ
    PLoS One; 2015; 10(8):e0136635. PubMed ID: 26317509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration of epitope recognition pattern in Ag85B and ESAT-6 has a profound influence on vaccine-induced protection against Mycobacterium tuberculosis.
    Bennekov T; Dietrich J; Rosenkrands I; Stryhn A; Doherty TM; Andersen P
    Eur J Immunol; 2006 Dec; 36(12):3346-55. PubMed ID: 17109467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T cells.
    Lindenstrøm T; Agger EM; Korsholm KS; Darrah PA; Aagaard C; Seder RA; Rosenkrands I; Andersen P
    J Immunol; 2009 Jun; 182(12):8047-55. PubMed ID: 19494330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the vaccine potential of Dec-205 targeting in Mycobacterium tuberculosis infection in mice.
    Stylianou E; Pepponi I; van Dolleweerd CJ; Paul MJ; Ma JK; Reljic R
    Vaccine; 2011 Mar; 29(12):2279-86. PubMed ID: 21272603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The in vivo expressed Mycobacterium tuberculosis (IVE-TB) antigen Rv2034 induces CD4⁺ T-cells that protect against pulmonary infection in HLA-DR transgenic mice and guinea pigs.
    Commandeur S; van den Eeden SJ; Dijkman K; Clark SO; van Meijgaarden KE; Wilson L; Franken KL; Williams A; Christensen D; Ottenhoff TH; Geluk A
    Vaccine; 2014 Jun; 32(29):3580-8. PubMed ID: 24837764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The LTK63 adjuvant improves protection conferred by Ag85B DNA-protein prime-boosting vaccination against Mycobacterium tuberculosis infection by dampening IFN-gamma response.
    Palma C; Iona E; Giannoni F; Pardini M; Brunori L; Fattorini L; Del Giudice G; Cassone A
    Vaccine; 2008 Aug; 26(33):4237-43. PubMed ID: 18584925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity and protective efficacy of a fusion protein vaccine consisting of antigen Ag85B and HspX against Mycobacterium tuberculosis infection in mice.
    Li Q; Yu H; Zhang Y; Wang B; Jiang W; Da Z; Xian Q; Wang Y; Liu X; Zhu B
    Scand J Immunol; 2011 Jun; 73(6):568-76. PubMed ID: 21323695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterologous prime-boost vaccination against tuberculosis with recombinant Sendai virus and DNA vaccines.
    Hu Z; Jiang W; Gu L; Qiao D; Shu T; Lowrie DB; Lu SH; Fan XY
    J Mol Med (Berl); 2019 Dec; 97(12):1685-1694. PubMed ID: 31786669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycobacterium tuberculosis PstS1 amplifies IFN-γ and induces IL-17/IL-22 responses by unrelated memory CD4+ T cells via dendritic cell activation.
    Palma C; Schiavoni G; Abalsamo L; Mattei F; Piccaro G; Sanchez M; Fernandez C; Singh M; Gabriele L
    Eur J Immunol; 2013 Sep; 43(9):2386-97. PubMed ID: 23719937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against Mycobacterium tuberculosis infection offered by a new multistage subunit vaccine correlates with increased number of IFN-γ+ IL-2+ CD4+ and IFN-γ+ CD8+ T cells.
    Wang X; Zhang J; Liang J; Zhang Y; Teng X; Yuan X; Fan X
    PLoS One; 2015; 10(3):e0122560. PubMed ID: 25822536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.